- 专利标题: 4′-or nucleosides for the treatment of HCV
-
申请号: US15104706申请日: 2014-12-17
-
公开(公告)号: US10683321B2公开(公告)日: 2020-06-16
- 发明人: David Dukhan , Cyril B. Dousson , Adel M. Moussa , Benjamin Alexander Mayes , Alistair James Stewart
- 申请人: IDENIX PHARMACEUTICALS LLC
- 申请人地址: US MA Cambridge
- 专利权人: Idenix Pharmaceuticals LLC
- 当前专利权人: Idenix Pharmaceuticals LLC
- 当前专利权人地址: US MA Cambridge
- 代理商 Jeffrey P. Bergman; Catherine D. Fitch
- 国际申请: PCT/US2014/070993 WO 20141217
- 国际公布: WO2015/095419 WO 20150625
- 主分类号: C07H19/207
- IPC分类号: C07H19/207 ; C07H19/10 ; C07H19/16 ; C07H19/06 ; C07H19/20 ; A61P31/14
摘要:
Provided herein are compounds, compositions and methods for the treatment of Flaviviridae infections, including HCV infections. In certain embodiments, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents. In certain embodiments, the compounds are 4′-OR nucleosides of Formula I: or a pharmaceutically acceptable salt thereof, wherein Base, PD, R, Z1, Z2, Z3, and Z4 are as defined herein.
公开/授权文献
- US20180162898A1 4'-OR NUCLEOSIDES FOR THE TREATMENT OF HCV 公开/授权日:2018-06-14